Sera Prognostics, Inc. (SERA)

NASDAQ: SERA · Real-Time Price · USD

1.910

-0.100 (-4.98%)

At close: Mar 18, 2026, 4:00 PM EDT

1.751

-0.159 (-8.31%)

After-hours: Mar 18, 2026, 7:59 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Developing and Commercializing Its Medical Diagnostic Products	77.00K	306.00K	268.00K	82.00K	25.00K
Developing and Commercializing Its Medical Diagnostic Products Growth	-74.84%	14.18%	226.83%	228.00%	-30.56%
Total	77.00K	306.00K	268.00K	82.00K	25.00K
Total Growth	-74.84%	14.18%	226.83%	228.00%	-30.56%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	77.00K	306.00K	268.00K	82.00K	25.00K
United States Growth	-74.84%	14.18%	226.83%	228.00%	-30.56%
Total	77.00K	306.00K	268.00K	82.00K	25.00K
Total Growth	-74.84%	14.18%	226.83%	228.00%	-30.56%

Source: S&P Global Market Intelligence.